The Procter & Gamble Company (NYSE:PG) is Cognios Beta Neutral Large Cap Fund LP’s 6th Largest Position

Cognios Beta Neutral Large Cap Fund LP trimmed its position in The Procter & Gamble Company (NYSE:PG) by 1.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 15,165 shares of the company’s stock after selling 207 shares during the quarter. Procter & Gamble comprises approximately 2.9% of Cognios Beta Neutral Large Cap Fund LP’s holdings, making the stock its 6th biggest position. Cognios Beta Neutral Large Cap Fund LP’s holdings in Procter & Gamble were worth $2,222,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Dfpg Investments LLC increased its stake in shares of Procter & Gamble by 1.7% during the fourth quarter. Dfpg Investments LLC now owns 24,892 shares of the company’s stock valued at $3,680,000 after buying an additional 424 shares during the period. Garrett Wealth Advisory Group LLC lifted its holdings in shares of Procter & Gamble by 6.3% during the third quarter. Garrett Wealth Advisory Group LLC now owns 4,419 shares of the company’s stock worth $645,000 after purchasing an additional 260 shares during the period. N.E.W. Advisory Services LLC lifted its holdings in Procter & Gamble by 14.6% in the third quarter. N.E.W. Advisory Services LLC now owns 94,424 shares of the company’s stock valued at $13,772,000 after acquiring an additional 12,016 shares during the period. Charles Schwab Investment Management Inc. lifted its holdings in Procter & Gamble by 0.8% in the third quarter. Charles Schwab Investment Management Inc. now owns 16,003,260 shares of the company’s stock valued at $2,298,184,000 after acquiring an additional 131,339 shares during the period. Finally, Miracle Mile Advisors LLC raised its stake in shares of Procter & Gamble by 105.5% during the 4th quarter. Miracle Mile Advisors LLC now owns 59,363 shares of the company’s stock worth $8,699,000 after buying an additional 30,473 shares during the period. 65.77% of the stock is owned by hedge funds and other institutional investors.

Procter & Gamble Price Performance

Procter & Gamble stock traded up $0.12 during mid-day trading on Monday, reaching $155.45. The company had a trading volume of 5,753,652 shares, compared to its average volume of 6,864,547. The company has a market cap of $365.78 billion, a P/E ratio of 26.04, a P/E/G ratio of 3.18 and a beta of 0.44. The business has a fifty day simple moving average of $159.27 and a 200 day simple moving average of $152.70. The company has a current ratio of 0.64, a quick ratio of 0.44 and a debt-to-equity ratio of 0.48. The Procter & Gamble Company has a fifty-two week low of $141.45 and a fifty-two week high of $163.14.

Procter & Gamble (NYSE:PG) last released its quarterly earnings results on Tuesday, January 23rd. The company reported $1.84 earnings per share for the quarter, topping the consensus estimate of $1.70 by $0.14. The business had revenue of $21.44 billion for the quarter, compared to analysts’ expectations of $21.48 billion. Procter & Gamble had a net margin of 17.60% and a return on equity of 34.04%. The firm’s revenue for the quarter was up 3.2% compared to the same quarter last year. During the same period in the previous year, the company earned $1.59 earnings per share. On average, equities research analysts predict that The Procter & Gamble Company will post 6.45 earnings per share for the current year.

Procter & Gamble Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be issued a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a yield of 2.59%. The ex-dividend date is Thursday, April 18th. This is a positive change from Procter & Gamble’s previous quarterly dividend of $0.94. Procter & Gamble’s dividend payout ratio is 62.98%.

Insider Buying and Selling

In other Procter & Gamble news, CEO R. Alexandra Keith sold 776 shares of the stock in a transaction on Monday, March 4th. The shares were sold at an average price of $158.11, for a total transaction of $122,693.36. Following the completion of the sale, the chief executive officer now owns 4,859 shares of the company’s stock, valued at approximately $768,256.49. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other Procter & Gamble news, CEO R. Alexandra Keith sold 776 shares of the firm’s stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $158.11, for a total transaction of $122,693.36. Following the completion of the sale, the chief executive officer now directly owns 4,859 shares in the company, valued at approximately $768,256.49. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Marc S. Pritchard sold 101,704 shares of Procter & Gamble stock in a transaction that occurred on Wednesday, January 24th. The stock was sold at an average price of $153.57, for a total transaction of $15,618,683.28. Following the completion of the sale, the insider now owns 163,428 shares of the company’s stock, valued at $25,097,637.96. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 279,063 shares of company stock valued at $43,187,745. Company insiders own 0.17% of the company’s stock.

Wall Street Analysts Forecast Growth

PG has been the subject of a number of research analyst reports. Raymond James increased their price target on Procter & Gamble from $170.00 to $175.00 and gave the stock an “outperform” rating in a report on Wednesday, January 24th. Barclays boosted their price target on Procter & Gamble from $165.00 to $168.00 and gave the stock an “overweight” rating in a report on Friday. Royal Bank of Canada upped their target price on Procter & Gamble from $156.00 to $157.00 and gave the stock a “sector perform” rating in a research report on Wednesday, January 24th. JPMorgan Chase & Co. cut their price target on Procter & Gamble from $169.00 to $162.00 and set an “overweight” rating on the stock in a research note on Thursday, January 18th. Finally, Truist Financial upgraded Procter & Gamble from a “hold” rating to a “buy” rating and increased their price target for the stock from $160.00 to $175.00 in a research report on Monday, March 11th. Seven research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $168.53.

About Procter & Gamble

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.